Nicotinic acetylcholine receptor alpha6beta2 subtype (nAChR α6β2)

The Nicotinic acetylcholine receptor alpha6beta2 subtype is a pentameric ligand-gated ion channel composed primarily of alpha 6 and beta 2 subunits. It belongs to the family of neuronal nicotinic acetylcholine receptors (nAChRs), which mediate fast synaptic transmission by converting chemical signals from acetylcholine into electrical signals via cation influx across cell membranes. The α6β2 subtype is predominantly expressed in select regions of the central nervous system—especially dopaminergic neurons—and plays a key role in modulating neurotransmitter release involved in reward pathways, motor control, and cognitive function. This makes it an important therapeutic target for conditions such as Parkinson’s disease and nicotine addiction. The structure-function relationship depends on its unique subunit composition that determines pharmacological properties such as ligand affinity and ion permeability. Drugs can act as agonists or antagonists at these receptors; however, achieving high selectivity remains a challenge due to structural similarities among nAChR subtypes.[1][3]

Other names

nAChR α6β2Neuronal nicotinic acetylcholine receptor alpha6beta2Alpha6 beta2 nicotinic receptorCHRNA6/CHRNB2-containing nicotinic receptor (less common)

Drugs targeting this molecule typically act as either agonists or antagonists at the ligand-binding site between subunits. Mechanisms include: – Agonism: Activating the ion channel to allow cation influx and depolarization. – Antagonism: Blocking ACh binding or channel opening, inhibiting synaptic transmission.[3]